Prime Announces Voting Results of 2025 AGM

VANCOUVER, British Columbia, June 19, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. ('Prime' or the 'Company') (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announces that shareholder voting at the Company's Annual General and Special Meeting of shareholders held on June 19, 2025 (the 'Meeting') has resulted in the election of all the directors listed as nominees in management's information circular dated May 5, 2025 (the 'Circular'), as well as the approval of all matters presented. Summaries of the results of voting are provided below.
Prime is focused on the exploration and development of its wholly owned Los Reyes gold-silver project in Sinaloa State, Mexico ('Los Reyes' or the 'Project'). Recent highlights include:
Announcement that the Company is targeting the delivery of a Preliminary Economic Assessment ('PEA') reflecting a high return, high margin, low capital and long-life project at Los Reyes, based on drilling to the end of 2024 and extensive technical work completed to-date. The PEA is targeted for completion in Q3 2025.
Cash balance of approximately $32.9 million as at June 17, 2025.
In addition, the Company will shortly be publishing its third annual Environmental, Social and Corporate Governance report, which will be made available on its website, at: https://www.primeminingcorp.ca/sustainability/overview/
Meeting Results A total of 103,882,459 common shares were represented at the Meeting, representing 68.13% of the issued and outstanding common shares of the Company at the record date.
Number of Directors
Voting results for the resolution to set the number of directors to be elected at nine (9) are as follows:
Votes For
% For
Votes Against
% Against
103,219,008
99.36%
663,451
0.64%
Election of Directors
Voting results for the resolution approving the appointment of nominees are as follows:
Nominee
Votes For
% For
Votes Withheld
% Withheld
Murray John
98,399,590
96.05%
4,047,915
3.95%
Scott Hicks
102,005,338
99.57%
442,167
0.43%
Paul Sweeney
99,361,921
96.99%
3,085,584
3.01%
Andrew Bowering
97,037,576
94.72%
5,409,929
5.28%
Edie Hofmeister
79,134,692
77.24%
23,312,813
22.76%
Marc Prefontaine
101,007,267
98.59%
1,440,238
1.41%
Chantal Gosselin
101,118,850
98.70%
1,328,655
1.30%
Kerry Sparkes
81,918,002
79.96%
20,529,503
20.04%
Sunny Lowe
99,354,374
96.98%
3,093,131
3.02%
Appointment of Auditors
Voting results for the resolution to approve Davidson & Company LLP, Chartered Professional Accounts as auditor of the Company, and to authorize the directors to fix the remuneration are as follows:
Votes For
% For
Votes Withheld
% Withheld
100,914,857
97.14%
2,967,602
2.86%
Revised Omnibus Incentive Plan
Voting results for the resolution to approve adoption of a revised omnibus incentive plan, as further described in the Circular, are as follows:
Votes For
% For
Votes Against
% Against
97,926,055
95.59%
4,521,450
4.41%
Unallocated Entitlements Under Omnibus Incentive Plan
Voting results for the resolution to approve unallocated entitlements under the revised omnibus incentive plan, as further described in the Circular, are as follows:
Votes For
% For
Votes Against
% Against
89,794,404
87.65%
12,653,101
12.35%
2025 Outlook
The Company plans to continue its success-based approach to exploration to further identify new prospective targets, expand the existing resource, and infill drilling. Additional work will include geological mapping and geochemical sampling to identify further discovery areas.
On January 28, 2025, drilling was paused in response to a deterioration in the security situation in parts of Sinaloa, including the Los Reyes area. This pause is not currently expected to impact the Company's ability to drill a minimum 40,000m program over 12-months from the recommencement of drilling. Six drill rigs remain on site and drill contractors are on standby to resume drilling as soon as security improves. The Company will continue to work with local authorities to monitor the current situation.
Planned fiscal 2025 exploration will focus on:
Extending the high-grade Z-T Area shoots that remain open at depth, as well as along strike, both north and south.
Expanding the known high-grade mineralization at Guadalupe East.
Increasing the Central Area resource through additions southeast at Noche Buena and its connection to San Miguel East.
Generative target drilling of high-grade intercepts at Las Primas, Fresnillo and Mariposa to further grow these emerging resources, as well as other target discovery areas to demonstrate the significant resource expansion potential at Los Reyes.
Project activities are also planned to include:
Preliminary Economic Assessment completion: Further refine metallurgical, geotechnical, mine planning and development parameters for project development, including process and underground mining optimization, infrastructure assessment and permitting requirements – targeting Q3 2025 completion.
Community Engagement: Continue to engage with and support local ejidos (communities) through educational, community and environmental programming, access (road) improvements and infrastructure development. Prime continues to sponsor and benefit from a strong geologist intern program, supporting geology students from local colleges and universities.
Figure 1 – Los Reyes Trends and Exploration TargetsAbout the Los Reyes Gold and Silver Project
Los Reyes is a high-grade, low-sulphidation epithermal gold-silver project located in Sinaloa State, Mexico. On October 15, 2024, Prime announced an updated multi-million-ounce high-grade open pit and underground resource based on exploration drilling up to July 17, 2024. Since acquiring Los Reyes in 2019, Prime has spent more than $64 million on direct exploration activities and has completed over 221,000 metres of drilling to date. The Company is targeting the delivery of a PEA by the end of Q3, 2025 that will highlight a high return, high margin, low capital and long-life project at Los Reyes.
October 15, 2024 Resource Statement1,2(based on a $1950/oz gold price, $25.24/oz silver price, economic-constrained estimate)
Mining Methodand Process
Class
Tonnage(kt)
Gold Grade (g/t)
Gold Contained(koz)
Silver Grade(g/t)
Silver Contained(koz)
Open Pit - Mill
Indicated
24,657
1.13
899
35.7
28,261
Inferred
7,211
0.89
207
42.8
9,916
Underground
Indicated
4,132
3.02
402
152.4
20,243
Inferred
4,055
2.10
273
78.6
10,247
Total Mill
Indicated
28,789
1.41
1,301
52.4
48,504
Inferred
11,266
1.33
480
55.7
20,163
Open Pit - Heap Leach
Indicated
20,254
0.29
190
8.4
5,492
Inferred
5,944
0.30
58
7.3
1,398
Total
Indicated
49,042
0.95
1,491
34.2
53,995
Inferred
17,210
0.97
538
39.0
21,561
Open Pit Resource estimates are based on economically constrained open pits generated using the Hochbaum Pseudoflow algorithm in Datamine's Studio NPVS and the following optimization parameters (all dollar values are in US dollars):
$1,950/ounce gold price and $25.24/ounce silver price.
Mill recoveries of 95.6% and 81% for gold and silver, respectively.
Heap leach recoveries of 73% and 25% for gold and silver, respectively.
Pit slopes by area ranging from 42-47 degrees overall slope angle.
5% ore loss and 5% dilution factor applied to the 5 x 5 x 5m open pit resource block models.
Mining costs of $2.00 per tonne of waste mined and $2.50 per tonne of ore mined.
Milling costs of $16.81 per tonne processed.
Heap Leach costs of $5.53 per tonne processed.
G&A cost of $2.00 per tonne of material processed.
3% royalty costs and 1% selling costs were also applied.
A 0.17 g/t gold only cutoff was applied to ex-pit processed material (which is above the heap-leaching NSR cutoff).
Underground Resource estimates are based on economically constrained stopes generated using Datamine's Mineable Shape Optimizer (MSO) algorithm and the following optimization parameters (all dollar values are in US dollars):
$1,950/ounce gold price and $25.24/ounce silver price.
Mill recoveries of 95.6% and 81% for gold and silver, respectively.
Mechanized cut and fill mining with a $60.00 per tonne cost.
Diluted to a minimum 4m stope width with a 98% mining recovery.
G&A cost of $4.00 per tonne of material processed.
Milling costs of $16.81 per tonne processed.
3% royalty costs and 1% selling costs were also applied.
Where mentioned, 'residual open pits' assumes that any underground stopes are backfilled with zero grade material at two-thirds of the original rock density. Economic-constrained open pits are then estimated with this mined-out, backfilled material in the open pit block selective mining unit ('SMU') model and assuming the resource parameters above.
Mineral Resources are not Mineral Reserves (as that term is defined in the CIM Definition Standards) and do not have demonstrated economic viability.
Refer to the Additional Notes section for further information.
Drilling and geological interpretation suggests that the three known main deposit areas (Guadalupe, Central and Z-T) are larger than previously reported. Potential also exists for new discoveries where mineralized trends have been identified outside of the currently defined resource areas. Historic operating results indicate that an estimated 1 million ounces of gold and 60 million ounces of silver were recovered from five separate operations at Los Reyes between 1770 and 1990. Prior to Prime's acquisition, recent operators of Los Reyes had spent approximately US$20 million on exploration, engineering, and prefeasibility studies.
QA/QC Protocols and Sampling Procedures
Drill core at the Los Reyes project is drilled in predominantly HQ size (63.5 millimetres 'mm'), reducing to NQ (47.6 mm) when required. Drill core samples are generally 1.50 m long along the core axis with allowance for shorter or longer intervals if required to suit geological constraints. After logging intervals are identified to be sampled, the core is cut and one half is submitted for assay.
Sample QA/QC measures include unmarked certified reference materials, blanks, and field duplicates as well as preparation duplicates are inserted into the sample sequence and make up approximately 8% of the samples submitted to the laboratory for each drill hole.
Samples are picked up from the Project by the laboratory personnel and transported to their facilities in Durango or Hermosillo, Mexico, for sample preparation. Sample analysis is carried out by Bureau Veritas and ALS Labs, with fire assay, including over limits fire assay re-analysis, completed at their respective Hermosillo, Mexico laboratories and multi-element analysis completed in Vancouver, Canada. Drill core sample preparation includes fine crushing of the sample to at least 70% passing less than 2 mm, sample splitting using a riffle splitter, and pulverizing a 250 gram split to at least 85% passing 75 microns.
Gold in diamond drill core is analyzed by fire assay and atomic absorption spectroscopy of a 30 g sample (code FA430 or Au-AA23). Multi-element chemistry is analyzed by 4-Acid digestion of a 0.25-gram sample split (code MA300 or ME-ICP61) with detection by an inductively coupled plasma emission spectrometer for a full suite of elements.
Gold assay techniques FA430 and Au-AA23 have an upper detection limit of 10 g/t. Any sample that produces an over-limit gold value via the initial assay technique is sent for gravimetric finish via method FA-530 or Au-GRA21. Silver analyses by MA300 and ME-ICP61 have an upper limit of 200 g/t and 100 g/t, respectively. Samples with over-limit silver values are re-analyzed by fire assay with gravimetric finish FA530 or Au-GRA21.
Both Bureau Veritas and ALS Labs are ISO/IEC accredited assay laboratories.
Additional Notes
Prime's MRE as of October 15, 2024 is classified in accordance with the Canadian Institute of Mining, Metallurgy and Petroleum ('CIM') 'CIM Definition Standards - For Mineral Resources and Mineral Reserves' adopted by the CIM Council (as amended, the 'CIM Definition Standards') and in accordance with the requirements of NI 43-101. Mineral resources are not mineral reserves and do not have demonstrated economic viability.
Metres is represented by 'm'; 'etw' is Estimated True Width and is based on drill hole geometry or comparisons with other on-section drill holes; 'Au' refers to gold, and 'Ag' refers to silver; 'g/t' is grams per metric tonne; some figures may not sum due to rounding; Composite assay grades presented in summary tables are calculated using a Au grade minimum average of 0.20 g/t or 1.0 g/t as indicated in 'Au Cut-off' column of Summary Tables. Maximum internal waste included in any reported composite interval is 3.00 m. The 1.00 g/t Au cut-off is used to define higher-grade 'cores' within the lower-grade halo.
Additional details are available in the associated Technical Report, filed on November 27, 2024.
Qualified Person
Scott Smith, P.Geo., Executive Vice President of Exploration, is a Qualified Person for the purposes of NI 43-101 and has reviewed and approved the technical content in this news release.
About Prime Mining
Prime is managed by an ideal mix of successful mining executives, strong capital markets personnel and experienced local operators all focused on unlocking the full potential of the Project. The Company has a well-planned capital structure with a strong management team and insider ownership. Prime is targeting a material resource expansion at Los Reyes through a combination of new generative area discoveries and growth, while also building on technical de-risking activities to support eventual project development.
For further information, please visit https://www.primeminingcorp.ca/ or direct enquiries to:
Scott HicksCEO & Director
Indi GopinathanVP Capital Markets & Business Development
Prime Mining Corp.710 – 1030 West Georgia St.Vancouver, BC V6E 2Y3 Canada+1(604) 238-1659info@primeminingcorp.ca
Cautionary Notes to U.S. Investors Concerning Resource EstimatesThis news release has been prepared in accordance with the requirements of the securities laws in effect in Canada, which differ from the requirements of the U.S. securities laws. In particular, and without limiting the generality of the foregoing, the terms 'mineral reserve', 'proven mineral reserve', 'probable mineral reserve', 'inferred mineral resources,' 'indicated mineral resources,' 'measured mineral resources' and 'mineral resources' used or referenced in this presentation are Canadian mineral disclosure terms as defined in accordance with NI 43-101 under the guidelines set out in the CIM Standards. The CIM Standards differ from the mineral property disclosure requirements of the U.S. Securities and Exchange Commission (the 'SEC') in Regulation S-K Subpart 1300 (the 'SEC Modernization Rules') under the U.S. Securities Act of 1933, as amended (the 'Securities Act'). As a foreign private issuer that is eligible to file reports with the SEC pursuant to the multijurisdictional disclosure system, the Company is not required to provide disclosure on its mineral properties under the SEC Modernization Rules and will continue to provide disclosure under NI 43-101 and the CIM Standards. Accordingly, the Company's disclosure of mineralization and other technical information may differ significantly from the information that would be disclosed had the Company prepared the information under the standards adopted under the SEC Modernization Rules.
Forward Looking Information
This news release contains certain 'forward-looking information' and 'forward-looking statements' within the meaning of Canadian securities legislation as may be amended from time to time, including, without limitation, statements regarding the perceived merit of the Company's properties, including additional exploration potential of Los Reyes, potential quantity and/or grade of minerals, the potential size of the mineralized zone, metallurgical recoveries, and the Company's exploration and development plans in Mexico. Forward-looking statements are statements that are not historical facts which address events, results, outcomes, or developments that the Company expects to occur. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve several risks and uncertainties. Certain material assumptions regarding such forward-looking statements were made, including without limitation, assumptions regarding the price of gold, silver and copper; the accuracy of mineral resource estimations; that there will be no material adverse change affecting the Company or its properties; that all required approvals will be obtained, including concession renewals and permitting; that political and legal developments will be consistent with current expectations; that currency and exchange rates will be consistent with current levels; and that there will be no significant disruptions affecting the Company or its properties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements involve significant known and unknown risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks include, but are not limited to: risks related to uncertainties inherent in the preparation of mineral resource estimates, including but not limited to changes to the cost assumptions, variations in quantity of mineralized material, grade or recovery rates, changes to geotechnical or hydrogeological considerations, failure of plant, equipment or processes, changes to availability of power or the power rates, ability to maintain social license, changes to interest or tax rates, changes in project parameters, delays and costs inherent to consulting and accommodating rights of local communities, environmental risks, title risks, including concession renewal, commodity price and exchange rate fluctuations, risks relating to COVID-19 and other future pandemics, delays in or failure to receive access agreements, on-going receipt of amended and/or operating permits, risks inherent in the estimation of mineral resources; and risks associated with executing the Company's objectives and strategies, including costs and expenses, physical access to the property, security risks, availability of contractors and skilled labour, as well as those risk factors discussed in the Company's most recently filed management's discussion and analysis, as well as its annual information form dated March 25, 2024, available on www.sedarplus.ca. Except as required by the securities disclosure laws and regulations applicable to the Company, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7e0e2885-5bc0-4e47-b3d2-beab965b0f0eSign in to access your portfolio

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

an hour ago

• Yahoo

BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, June 20, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has amended the terms of its brokered private placement LIFE financing (the "Offering") previously announced on May 30, 2025, and filed an amended offering document (the "Amended Offering Document"). The Amended Offering Document updates the exercise price of the common share purchase warrant that forms part of the units ("Units") being offered by the Company from a post-consolidation exercise price of $0.60 to a post-consolidation exercise price of $0.50. As previously announced, the Company intends to consolidate the common shares of the Company (the "Common Shares") on the basis of ten (10) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the "Consolidation"), and complete a concurrent Offering consisting of a minimum of 5,714,285 Units at a post-Consolidation price of $0.35 per Unit for minimum gross proceeds of $2,000,000 and a maximum of 8,571,428 Units at a post-Consolidation price of $0.35 per Unit for maximum gross proceeds of up to $3,000,000. Each Unit will consist of one (1) post-Consolidation common share in the capital of the Company (each, a "Post-Consolidation Common Share") and one (1) Post-Consolidation Common Share purchase warrant (each, a "Post-Consolidation Warrant"). Each Post-Consolidation Warrant will entitle the holder thereof to purchase one Post-Consolidation Common Share at a post-Consolidation price of $0.50 for a period of 36 months from the closing date of the Offering. Closing of the Offering is anticipated to occur on or about June 30, 2025, or such other date as the Company may agree upon provided such date is on or before July 14, 2025. Closing of the Offering is subject to the satisfaction of certain conditions, including, but not limited to, acceptance by the CSE. The Company intends to use the net proceeds raised from the Offering for research and development, general corporate purposes and working capital. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), the Units issuable under the Offering will be offered for sale to purchasers in all provinces and territories of Canada, except Quebec, pursuant to the listed issuer financing exemption ("LIFE") under Part 5A of NI 45-106. The securities to be issued pursuant to the sale of the Units under the Offering will not be subject to resale restrictions in accordance with applicable Canadian securities laws. There is an Amended Offering Document dated June 18, 2025, related to the Offering that can be accessed under the Company's profile at and on the Company's website at Prospective investors should read this offering document before making an investment decision. This news release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States, or in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it's HapTenix© tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergy, and other immunological diseases. Through a differentiated mechanism of action, the DPX™ platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. The Company's clinical stage pipeline includes maveropepimut-S (MVP-S), based on the DPX™ platform, and in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers, and also delivers an innate immune activator and a universal CD4 T cell helper peptide. MVP-S has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. BioVaxys is also developing DPX™+SurMAGE, a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV for Respiratory Syncytial Virus, DPX+rPA for peanut allergy prophylaxis, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix© 'neoantigen' tumor cell construct platform for refractive late-stage ovarian cancer. BioVaxys common shares are listed on the CSE under the stock symbol "BIOV" and trade on the Frankfurt Bourse (FRA: 5LB) and in the U.S. on the OTC Markets (OTCQB marketplace). For more information, visit and connect with us on X and LinkedIn. ON BEHALF OF THE BOARDSigned "James Passin" James Passin, Chief Executive OfficerPhone: +1 740 358 0555 Cautionary Statements on Forward Looking Information This news release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the future operating or financial performance of the Company, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. Forward-looking statements in this news release relate to, among other things, the proposed Consolidation, including the ratio thereof and timing thereof, and the Offering, including the size and use of proceeds, and the timing and ability of the Company to close the Offering, including obtaining approval of the Offering from the CSE. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by BioVaxys, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies including, primarily but without limitation, the risk that BioVaxys' vaccines will not prove to be effective and/ or will not receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about whether its products will complete the long, complex and expensive clinical trial and regulatory approval process for approval of new drugs necessary for marketing approval, uncertainty about whether its autologous cell vaccine immunotherapy can be developed to produce safe and effective products and, if so, whether its vaccine products will be commercially accepted and profitable, the expenses, delays and uncertainties and complications typically encountered by development stage biopharmaceutical businesses, financial and development obligations under license arrangements in order to protect its rights to its products and technologies, obtaining and protecting new intellectual property rights and avoiding infringement to third parties and their dependence on manufacturing by third parties. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the ability of the Company to complete the Consolidation and the Offering on the terms proposed or at all, and the ability to obtain necessary approvals, including the approval of the CSE. BioVaxys does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by applicable securities laws. The CSE has not reviewed, approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this news release. Logo: View original content: SOURCE BioVaxys Technology Corp. View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

an hour ago

• Yahoo

Vancouver council approves controversial Commercial Drive rental tower project

Vancouver city council has voted to approve the rezoning of a site near the Commercial-Broadway SkyTrain station, which is set to add more than 1,000 housing units across three towers. Westbank Projects Corp. and Crombie REIT, on behalf of Snowcat Property Holdings, brought forward the proposal in 2023 to redevelop the site at 1780 East Broadway, which presently houses a Safeway supermarket and a car park. There have been proposals to redevelop the site as far back as 2019, and now that rezoning has been approved, the controversial rental towers will proceed as planned. They range in height from 36 to 43 storeys in an area that consists mostly of single-family homes, duplexes, low-rise apartments and retail buildings.A marathon public hearing saw over 100 people talk to council about the project, with critics saying the tall towers would lead to inflated property values in the area and that they would not be affordable for a majority of Vancouverites. Ultimately, however, a majority of councillors voted in favour of the project, particularly talking up an accompanying retail space — including a grocery store, office and commercial space, a city-owned child-care facility, and a public plaza running parallel to the SkyTrain station. "I don't want to see this site remain undeveloped for another 10 or 20 years," Coun. Lucy Maloney said. "I want to see a surface car park replaced with over 1,000 homes." The units will be built across the three towers. Ten per cent of them will be secured at city-wide average rental market rates and the other 90 per cent listed at prices of the developer's choosing. Maloney acknowledged that many speakers at the public hearing expressed concern about the affordability of the housing, but said "if this project fails, there will be no affordable homes at all." Coun. Sean Orr said he thought using city-wide average rents for the 10 per cent of more affordable units was flawed, given how sky-high rents are in Vancouver. "We need rental units, but I'm worried that we are giving the developer double the height and we're not seeing the full public benefits that we could be seeing at the site," he told council. Orr was the only councillor who voted against the proposal, with Coun. Pete Fry abstaining and Coun. Brian Montague absent. Application under community plan The application was considered under the Grandview-Woodland Community Plan. A referral report from city staff notes that the application "exceeds the anticipated height and density expected in the plan," but "otherwise generally meets the intent of the plan." Proponents of the plan argued that the city was in dire need of rental spaces, with one advocate even playing the accordion in city council during the public hearing to encourage councillors to vote in favour. "There's zero displacement of renters. It's mostly just a parking lot," said advocate Peter Waldkirch in a statement. However, the megatowers also faced sharp criticism. Speaking against the proposal, nurse Nancy Hay asked council to vote for rezoning applications guaranteeing at least 20 per cent below-market rental units, saying that many of her coworkers in the health-care sector could not afford to live in Vancouver due to skyrocketing rents. "I wonder if these monoliths, these proposed monolith towers, are going to house workers ... who are these workers going to be?" she asked. "They will not be my coworkers — health-care workers, lab technicians, respiratory therapists, occupational therapists, to name a few occupations ... the proposed rent, as you've heard, is way too expensive."

Bloomberg

2 hours ago

• Bloomberg

Japan Chemicals Firm CEO Fights to Keep Job as Investors Revolt

In a sign of rising shareholders' activism, a president of a semiconductor material maker is at risk of getting voted out of office at the firm's annual general meeting Saturday. Eiji Sato is facing an uphill battle to be re-appointed as president and CEO of Taiyo Holdings Co., a position he has held since 2011, after some shareholders criticized his response to various acquisition proposals as being too slow.